16 Jun 2011 Inviragen Initiates Phase 1 Study of Hand, Foot and Mouth Disease Vaccine in Singapore
16 Jun 2011 BiondVax Announces Positive Phase IIa Results for Universal Flu Vaccine
14 Jun 2011 Arecor and GSK Form Collaboration to Advance New Vaccines
14 Jun 2011 GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
13 Jun 2011 Circassia's Rapid Four-Dose ToleroMune Treatment Maintains Significant Reduction in Allergy Symptoms During 12-Month Follow-up
10 Jun 2011 The Juvenile Diabetes Research Foundation and Selecta Biosciences Enter Research Collaboration for Vaccines for Type 1 Diabetes
09 Jun 2011 ImmunoCellular Therapeutics Ltd. Expands Phase II Trial of ICT-107
09 Jun 2011 Isconova enters into adjuvant license agreement with Crucell
08 Jun 2011 Medicago reports positive U.S. clinical trial results for its H1N1 / seasonal influenza vaccine
08 Jun 2011 Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
08 Jun 2011 RXi Pharmaceuticals Presents Additional Positive Phase 2 Efficacy Results for Combination of NeuVaxTM (E75) and Trastuzumab Breast Cancer at ASCO
06 Jun 2011 Vaxart Begins First Oral Vaccine Clinical Trial
06 Jun 2011 Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has begun dosing volunteers in a Phase I clinical trial
06 Jun 2011 BioSante Pharmaceuticals Announces Lifting of Clinical Hold on GVAX Prostate Cancer Vaccine
06 Jun 2011 Stemline Therapeutics, Inc. Announces Oral Presentation of Positive Phase I/II Trial Results with Novel Brain Cancer Vaccine at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting
06 Jun 2011 New Data From Phase 2 Brain Cancer Study With Prophage Series G-200 (HSPPC-96) Shows Improved Overall Survival
06 Jun 2011 Cellectis and VitamFero Collaborate to Develop Vaccines against Parasitic Infection
02 Jun 2011 Fraunhofer USA CMB Announces Positive Phase 1 Interim Results for Its Plant-Produced H1N1 Influenza Vaccine
01 Jun 2011 GlobeImmune Reports Positive Results for Two Therapeutic Vaccines, GI-4000 and GI-6207
01 Jun 2011 Immunovaccine Announces Immune Results from Phase I Trial for DPX-0907 Therapeutic Cancer Vaccine
01 Jun 2011 Diamyd regains control of diabetes therapy
01 Jun 2011 Profectus BioSciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Immunogenicity of a Vesicular Stomatitis Virus-vectored HIV-1 Vaccine
26 May 2011 Medicago announces research collaboration for the development of a VLP vaccine candidate for the prevention of Ebola with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
26 May 2011 Dynavax Completes Phase 3 Study of HEPLISAV(TM)
26 May 2011 Isconova initiates influenza study vaccinations

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up